Enzymatic nucleic acids that cleave C-fos

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 9131, 4353201, 435325, 435375, C07H 2104, C12P 1934, C12N 1563, C12N 1585

Patent

active

061038903

ABSTRACT:
Enzymatic nucleic acid molecules which cleave c-fos RNA.

REFERENCES:
patent: 4987071 (1991-01-01), Cech et al.
patent: 5168053 (1992-12-01), Altman
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5334711 (1994-08-01), Sproat et al.
patent: 5525468 (1996-06-01), McSwiggen
Gura, T. Science. vol. 278, pp. 1041-1042 ( Nov. 1997).
Crooke , S.T. in Antisense Research and Application ( Stanley T. Crooke, Ed), Springer-Verlag, pp. 1-50, (Jul. 1998).
Branch, A.D. TIBS. vol. 23, pp. 45-50 (Feb. 1998).
Gewirtz, A.M. et al. Proc. Natl. Acad. Sci. USA. vol. 93, pp. 3161-3163 ( Apr. 1996).
Rojanasakul, Y. Advanced Drug Delivery Reviews. vol. 18, pp. 115-131 (Jan. 1996).
Anderson, W.F. Nature. vol. 392, Suppl. pp. 25-30 (Apr. 1998).
Aktar et al., "Cellular Uptake and Intracellular Fate of AntiSense Oligonucleotides, " Trends Cell Biol. 2:139-144 (1992).
Alitalo et al., "Aberrant Expression of An Amplified c-myb Oncogene in Two Cell Lines From a Colon Carcinoma," Proc. Natl. Acad. Sci. USA 81:4534-4538 (1984).
Anfossi et al., "An Olitomer Complementary to c-myb-encoded Mrna Inhibits Proliferation of Human Myeloid Leukemia Cell Lines," Proc. Natl. Acad. Sci. USA 86:3379-3383 (1979).
Angel et al., "The Role of Jun, Fos and the AP-1 Complex in Cell-Proliferation and Transformation," Biochimica et Biosphysica Acta 1072:129-157 (1991).
Austin et al., "Intimal Proliferation of Smooth Muscle Cells as an Explanation for Recurrent Coronary Artery Stenosis After Percutaneous Transluminal Coronary Angioplasty," JACC 6(2):369-75 (1985).
Belaaouaj et al., "Human Macrophage Metalloelastase," J. Biol. Chem. 270(24):14568-14575 (1995).
Bennett et al., "Cationic Lipids Enhance Cellular Uptake and Activity of Phosphorothioate Antisense Oliogonucleotides," Mol. Pharmacol. 41:1023-1033 (1991).
Burgin et al., "Chemically Modified Hammerhead Ribozymes with Improved Catalytic Rates," Biochem. 35:14090-14097 (1996).
Carter, "Adeno-associated Virus Vectors," Curr. Opi. Biotech. 3:533 (1992).
Cech, "Ribozymes and Their Medical Implications," JAMA 260:3030 (1988).
Chen et al., "Multitarget-ribozyme Directed to Cleave at up to Nine Highly Conserved HIV-1 Env RNA Regions Inhibits HIV-1 Replication--Potential Effectiveness Against Most Presently Sequenced HIV-1 Isolates," Nucl. Acid Res. 20(17):4581-4589 (1992).
Chowrira et al., "Extensive Phosphorothioate Substitution Yields Highly Active and Nuclease-resistant Hairpin Ribozymes," Nucl. Acids Res.20(11):2835-2840 (1992).
Chowrira et al., "In Vitro and In Vivo Comparison of Hammerhead, Hairpin and Hepatitis Delta Virus Self-processing Ribozyme Cassettes," J. of Biol. Chem. 269(41):25856-25864 (1994).
Christofferson et al., "Ribozymes as Human Therapeutic Agents," Am. Chem. Soc.38(12):2023-2037 (1995).
Christofferson et al., "Application of Computational Technologies to Ribozyme Biotechnology Products, " J. Mol. Struc. Theochem. 311:273 (1994).
Collins and Olive, "Reactions Conditions and Kinetics of Self-Cleavage of a Ribozyme Derived from Neurospora VS RNA, " Biochemistry 32:2795-2799 (1993).
Contrino et al., In Situ Detection of Tissue Factor in Vascular Endothelial Cells: Correlation with the Malignant Phenotype of Human Breast Disease, Nature Med.2:209 (1996).
Couture et al., "Anti-Gene Therapy: Use of Ribozymes to Inhibit Gene Function," TIG12(12):510 (1996).
Dreyfus, "Restriction Ribozymes?" Einstein J. of Biol. And Med.6(2):92-93 (1988).
Dropulic et al., "Functional Characterization of a U5 Ribozyme: Intracellular Suppression of Human Immunodeficiency Virus type 1 Expression," J.of Virol. 66(3):1432-1441 (1992).
Elroy-Stein et al., "Cytoplasmic Expression System Based on Constitutive Synthesis of Bacteriophage T7RNA Polymerase in Mammalian Cells," Proc. Natl. Acad. Sci. USA 87:6743-6747 (1990).
Feldstein et al., "Two Sequences Participating in the Autolytic Processing of Satellite Tobacco Ringspot Virus Complementary RNA, " Gene 82:53-61 (1989).
Felts et al., "Tissue Factor Gene Transcription in Serum-Stimulated Fibroblasts Is Mediated by Recruitment of c-Fos into Specific AP-1 DNA-Binding Complexes," Biochemistry 34:12355 (1995).
Forster et al., "External Guide Sequences for an RNA Enzyme," Science 249:783-786 (1990).
Ritchlin and Winchester, "Potential Mechanisms for Coordinate Gene Activation in the Rheumatoid Synoviocyte: Implications and Hypotheses," Springer Semin. Immunopathol. 11:219 (1989).
Rochefort, "Oestrogen-and Anti-Oestrogen-Regulated Genes in Human Breast Cancer," Oestrogens and Breast Cancer 254-268 (1995).
Rossi et al., "Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applicationsm and Problems" Aids Res. And Human Retro. 8(2):183-189 (1992).
Ruther et al.,"c-fos Expression Induces Bone Tumors in Transgenic Mice," Oncogene 4:861-865 (1989).
Saarialho-Kere et al., "Distinct Localization of Collagenase and Tissue Inhibitor of Metalloproteinases Expression in Wound Healing Associated with Ulcerative Pyogenic Granuloma," J. Clin. Invest. 90:1952-1957 (1992).
Sarver et al., "Ribozymes as Potential Anti-HIV-1 Therapeutic Agents," Science 247:1222-1225 (1990).
Sato et al., "Regulatory Mechanism of 92kDa Type IV Collagenase Gene Expression Which is Associated with Invasiveness of Tumor Cells," Oncogene 8:395-405 (1993).
Saville and Collins, "A Site-Specific Self-Clevage Products of a Neurospora Mitochondrial Plasmid Transcript," Proc. Natl. Acad. Sci. 88:8826-8830 (1991).
Scanlon et al., "Ribozyme-Mediated Reversal of the Multidrug-Resistant Phenotype," Proc. Natl. Acad. Sci. USA 91:11123 (1994).
Scanlon et al., "Ribozyme-Mediated Cleavage of C-fos mRNA Reduces Gene Expression of DNA Synthesis Enzymes and Metallothionein," Proc. Natl. Acad. Sci. USA 88: 10591-10595 (1991).
Scaringe et al., "Chemical Synthesis of Biologically Active Oligoribonucleotides Using .beta.-cyanoethyl Protected Ribonucleoside Phosphoramidites," Nucl.Acids Res.18(18):5433-5441 (1990).
Taira et al., "Construction of a Novel RNA-Transcript-Trimming Plasmid Which can be Used both In Vitro in Place of Run-off and (G)-free Transcriptions and In Vivo as Multi-Sequences Transcription Vectors, " Nucl. Acids Res. 19(19):5125-5130 (1991).
Thompson et al., "Improved Accumulation and Activity of Ribozymes Expressed from a tRNA-based RNA Polymerase III Promoter," Nucl. Acids Res. 23(12):2259-2268 (1995).
Troen et al., "Downstream Sequences Mediate Induction of the Mouse Carhepsin L Promoter by Phorbol Ester," Cell Growth & Diff. 2:23-31 (1991).
Uhlenbeck, "A Small Catalytic Oligoribonucleotide, " Nature 328:596-600 (1987).
Usman et al., "Automated Chemical Synthesis of Long Oligoribonucleotides Using 2'-O-Silylated Ribonucleoside 3'-O-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3'-Half Molecule of an Escherichia Coli Formylmethionine tRNA," Am. Chem. Soc. 109:7845-7854 (1987).
Usman et al., "Chapter 30. Catalytic RNA (Ribozymes) as Drugs," Annual Reports in Medicinal Chem. 30: 285-294 (1995).
Lauricella-Lefebvre et al., "Stimulation of the 92-kD Type IV Collagenase Promoter and Enzyme Expression in Human Melanoma Cells," Invasion Metastasis 13:289-300 (1993).
Lengyel et al., "Stimulation of Urokinase Expression by TNF-.alpha.Requires the Activation of Binding Sites for the AP-1 and PEA3 Transcription Factors," Elsevier 1268:65-72 (1995).
Li et al., "Cleavage by Rnase P of Gene N mRNA Reduces Bacteriophage .lambda.Burst Size, " Nucl. Acids Res. 24(5):835-842 (1996).
Lieber et al., "Stable High-Level Gene Expression in Mammalian Cells by T7 Phage RNA Polymerase," Methods Enzymol. 217:47-66 (1993).
Lin et al., "Inhibition of Collagenase Type I Expression by Psoralen Antisense Oligonucleotides in Dermal Fibroblasts," The FASEB J. 9:1371-1377 (1995).
Lisziewicz et al., "Inhibition of Human Immunodificiency Virus Type 1 Replication by Regulated Expression of a Polymeric Tat Activation Response RNA Decoy as a Strategy for Gene Therapy in AIDS," Proc. Natl. Acad. Sci.USA 90:8000-8004 (1993).
MacDougall et al., "Contributions of Tumor and Stromal Matrix Metalloproteinases to Tumor Pro

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enzymatic nucleic acids that cleave C-fos does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzymatic nucleic acids that cleave C-fos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatic nucleic acids that cleave C-fos will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2008348

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.